Adverse events self-reported by patients with advanced non-small cell lung cancer treated with osimertinib or chemotherapy

被引：0
|
作者：
不详
机构：
来源：
ANNALS OF ONCOLOGY | 2017年 / 28卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
94PD
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Adverse events self-reported by patients with advanced non-small cell lung cancer treated with osimertinib or chemotherapy
    Sebastian, M.
    Ryden, A.
    Walding, A.
    Ghiorghiu, S.
    Rudell, K.
    Papadimitrakopoulou, V.
    ANNALS OF ONCOLOGY, 2017, 28
  • [2] Adverse events self-reported by patients with advanced non-small cell lung cancer treated with osimertinib or chemotherapy in the AURA3 trial
    Sebastian, M.
    Schuler, M.
    Schulz, C.
    Deschler-Baier, B.
    Kimmich, M.
    Hilgert-Daute, K.
    Griesinger, F.
    ONCOLOGY RESEARCH AND TREATMENT, 2018, 41 : 111 - 111
  • [3] Cardiac Adverse Events in EGFR-Mutated Non-Small Cell Lung Cancer Treated With Osimertinib
    Kunimasa, Kei
    Kamada, Risa
    Oka, Toru
    Oboshi, Makiko
    Kimura, Madoka
    Inoue, Takako
    Tamiya, Motohiro
    Nishikawa, Tatsuya
    Yasui, Taku
    Shioyama, Wataru
    Nishino, Kazumi
    Imamura, Fumio
    Kumagai, Toru
    Fujita, Masashi
    JACC: CARDIOONCOLOGY, 2020, 2 (01): : 1 - 10
  • [4] No benefit of chemotherapy in Osimertinib-treated postoperative non-small cell lung cancer patients
    Li, Feng
    Zhao, Yi
    Zhong, Ran
    Cai, Xiuyu
    Liu, Jun
    He, Jianxing
    Liang, Wenhua
    TRANSLATIONAL LUNG CANCER RESEARCH, 2021, 10 (08) : 3689 - 3693
  • [5] Self-Reported Depression Among Patients With Non-Small Cell Lung Cancer
    Li, Yumei
    Hou, Lili
    CANCER NURSING, 2016, 39 : S121 - S121
  • [6] Self-reported depression among patients with non-small cell lung cancer
    Shi, Yan
    Gu, Fen
    Hou, Li-li
    Hu, Yin-qing
    THORACIC CANCER, 2015, 6 (03) : 334 - 337
  • [7] Self-reported depression among patients with non-small cell lung cancer
    Gu, F.
    Hou, L. L.
    JOURNAL OF THORACIC ONCOLOGY, 2016, 11 (04) : S74 - S74
  • [8] THE RISK FACTORS FOR SEVERE ADVERSE EVENTS OF CHEMOTHERAPY FOR ADVANCED NON-SMALL CELL LUNG CANCER
    Suina, Kentaro
    Koyama, Ryo
    Shukuya, Takehito
    Asao, Tetsuhiko
    Honma, Yuichiro
    Kato, Motoyasu
    Muraki, Keiko
    Shimada, Naoko
    Sakuraba, Akiko
    Sakuraba, Kazuhisa
    RESPIROLOGY, 2013, 18 : 7 - 7
  • [9] CHEMOTHERAPY IN ADVANCED NON-SMALL CELL LUNG CANCER PATIENTS PREVIOUSLY TREATED WITH ADJUVANT CHEMOTHERAPY
    Valdes, Mario
    Goss, Glenwood
    Nicholas, Garth
    Wheatley-Price, Paul
    JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S583 - S583
  • [10] Patient-reported symptoms and impact of treatment with osimertinib vs chemotherapy for advanced non-small cell lung cancer
    Lee, C. K.
    Novello, S.
    Ryden, A.
    Templeton, A.
    Rudell, K.
    Mann, H.
    Ghiorghiu, S.
    Mok, T.
    ANNALS OF ONCOLOGY, 2017, 28
12345